
Examine how AI chat engines cite drugmakers compared with where pharmaceutical companies spend on direct-to-consumer advertising, revealing visibility mismatches.
Key Takeaways
- 5W found AI citation shares via 60+ patient prompts across five major engines
- Eli Lilly holds an estimated 12.5% AI citation share
- Novo Nordisk holds an estimated 11.5% AI citation share
